The WHO estimate that c 50% of all vaccines manufactured are wasted in spite of c $400m p.a. spent on the global Cold Chain. Stablepharma aims to ensure that all vaccines can be removed from the refrigerated cold chain and stored for months or even years at room temperature. The Problem: Vaccines are perishable requiring constant, precise refrigeration from the manufacturer to the patient, be it in a hospital or a remote clinic in Africa. The Solution: StablevaX is a patented invention which enables vaccines to be transported & stored for many years without refrigeration whilst complying with current protocols set by the WHO. It’s an important breakthrough that can save many lives. Stablepharma has partnered with a WHO pre-qualified European vaccine manufacturer as well as world-class UK academic institutions, in order to advance our work on the thermo-stabilisation of T&D containing vaccines and mRNA vaccine technologies. Stablepharma was delighted to received an Innovate UK grant to progress our work in these areas. The StablevaX products comprise of approved vaccines and are intended to be pre-dosed. Join us in changing the future of healthcare!